Business » Biotechnology and Pharmaceuticals » Pharmaceuticals » Manufacturing	UPDATE INFO | REPORT BROKEN LINK
Novartis	Popularity:    Hit: 1071

Details:

Novartis is committed to improving the global quality of life through our broad portfolio of products and services in pharmaceuticals, generics, consumer health, and eye care and ophthalmics. URL: http://www.novartis.com/ Title: Novartis, an innovative healthcare products company with pharmaceutical treatments for heart disease, high blood pressure, diabetes, parkinsonOCOs, alzheimerOCOs, infectious disease and cancer. Image: Description: Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Manufacturing - Novartis. Novartis is committed to improving the global quality of life through our broad portfolio of products and services in pharmaceuticals, generics, consumer health, and eye care and ophthalmics. Similar:

Related Sites

Ipsen Limited (Popularity: ): Pharmaceutical company specializing in controlled release peptides and botulinum toxin. Eli Lilly and Company (Popularity: ): Information for health care professionals, patients, and consumers in the United States only. All American Pharmaceutical (Popularity: ): Manufacturer of liquids, capsules, powders and tablets providing custom labeling and formulation. Features information about manufacturing and packing prices, as ... Procter & Gamble (Popularity: ): We will provide products of superior quality and value that improve the lives of the world's consumers. Strides Arcolab Limited (Popularity: ): Niche products in the pharmaceutical/nutrition industry. Solvay Group (Popularity: ): International group of companies engaged in research, development, production, marketing, and sale of pharmaceuticals, chemicals, plastics, and plastic processing products. Orchid Chemicals & Pharmaceuticals Ltd. (Popularity: ): Cephalosporin and other pharmaceutical products. Sigma-Tau Pharmaceuticals (Popularity: ): Pharmaceutical manufacturer and distributor developing or acquiring and making available products based on naturally-occurring substances that enhance the body's natural ... NNODUM Corporation (Popularity: ): Triple action Formula for arthritis, bursitis, rheumatism, muscle aches and pain, diabetic neuropathy, sprains and strains. Boehringer-Ingelheim Pharmaceuticals (Popularity: ): Main site of Boehringer Ingelheim (Germany) that ranks among the top 20 pharmaceutical companies in the world. Features global activities, ...

Popular Sites

Ointment Suppliers India (Popularity: ): One of the market leader gmp certified manufacturing company of ointments in india, engaged in supplying wide range of quality ... Purna Pharmaceuticals - Belgium (Popularity: ): A third party manufacturer of pharmaceuticals, cosmetics and nutrients. Specialized in manufacturing of creams, ointments and gels, several solutions, and ... Herbal Medicine for Skin Diseases (Popularity: ): Indian pharmaceutical company engaged in manufacture and marketing of research based formulations for treatment of PSORIASIS,VITILIGO,IMMUNE DEFICIENCIES,HAIR FALL, DANDRUFF, DRY ... Ipsen Limited (Popularity: ): Pharmaceutical company specializing in controlled release peptides and botulinum toxin. Vetal Veterinary Vaccines and Pharmaceuticals (Popularity: ): Producers of pox for sheep-goats and clostridial vaccines. Also makes all main veterinary vaccines, including foot and mouth disease and ...

Related Press

Novartis committed to making Galvus® available for patients with type 2 diabetes after US regulators issue "approvable letter" (Popularity: ): * Novartis confident in safety and efficacy of Galvus as a once-daily oral treatment for patients with type 2 diabetes, ... 4-Antibody AG Closes CHF 6 Million Series A Financing and Appoints Sijmen de Vries as CEO (Popularity: ): 4-Antibody, a Basel-based biotechnology company focused on exploiting its proprietary platform to develop de novo and improved fully human antibodies, ... Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 (Popularity: ): Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launches ... Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ... FDA Approves Vaccines for the 2010-2011 Influenza Season (Popularity: ): The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the ...